Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas Aaberg, Jr, MD
Neurotech Pharmaceuticals, LLC
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Save Sight Institute
Sydney, New South Wales, Australia
- Centre for Eye Research Australia
East Melbourne, Victoria, Australia
- Lions Eye Institute
Nedlands, Western Australia, Australia
- Jules Stein Eye Institute
Los Angeles, California, United States
- National Eye Institute
Washington D.C., District of Columbia, United States
- Bascom Palmer
Miami, Florida, United States
- Massachusetts Eye and Ear Infirmary, Retina Service
Boston, Massachusetts, United States
- University of Michigan, Kellogg Eye Center
Ann Arbor, Michigan, United States
- Retina Associates of Cleveland, Inc.
Beachwood, Ohio, United States
- Retina Consultants of Texas
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Jul 2021
- Primary completion
- 8 Dec 2022
- Completion
- 8 Dec 2022
- Last update posted
- 26 Mar 2025
- Registered enrollment
- 33
- Registry id
- NCT04729972
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.